Divis Laboratories is currently trading at Rs. 937.00, up by 10.30 points or 1.11% from its previous closing of Rs. 926.70 on the BSE.
The scrip opened at Rs. 936.90 and has touched a high and low of Rs. 940.10 and Rs. 905.00 respectively. So far 2,844 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1233.00 on 30-Nov-2012 and a 52 week low of Rs. 905.00 on 05-Aug-2013.
Last one week high and low of the scrip stood at Rs. 970.00 and Rs. 906.15 respectively. The current market cap of the company is Rs. 12,437 crore.
The promoters holding in the company stood at 52.15% while Institutions and Non-Institutions held 27.35% and 20.50% respectively.
On standalone basis, the company has posted a rise of 4.38% in its net profit at Rs 174.71 crore for the quarter ended June 30, 2013 as compared to Rs 167.38 crore for the same quarter in the previous year. The total income of the company has increased by 11.84% to Rs 570.57 crore for quarter under review as compared to Rs 510.17 crore for the quarter ended June 30, 2012.
Divis Laboratories, together with its subsidiaries, engaged in the manufacture and sale of active pharma ingredients (APIs) and intermediates for the pharmaceutical industry in India and worldwide.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1837.30 |
Dr. Reddys Lab | 1370.60 |
Cipla | 1495.05 |
Lupin | 2252.40 |
Zydus Lifesciences | 981.55 |
View more.. |